Mankind Pharma Limited (MANKIND.NS)
INR 2845.85
(1.42%)
INR 2845.85
(1.42%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.07 Billion INR | 21.6% |
| 2022 | 1.7 Billion INR | -80.49% |
| 2021 | 8.73 Billion INR | 262.79% |
| 2020 | 2.4 Billion INR | 83.87% |
| 2019 | 1.3 Billion INR | -51.57% |
| 2018 | 2.7 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.79 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 2.07 Billion INR | 0.0% |
| 2023 FY | 2.07 Billion INR | 21.6% |
| 2022 Q4 | 1.7 Billion INR | -3.34% |
| 2022 FY | 1.7 Billion INR | -80.49% |
| 2022 Q3 | 1.76 Billion INR | 0.0% |
| 2021 Q4 | 8.73 Billion INR | 0.0% |
| 2021 FY | 8.73 Billion INR | 262.79% |
| 2020 FY | 2.4 Billion INR | 83.87% |
| 2019 FY | 1.3 Billion INR | -51.57% |
| 2018 FY | 2.7 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | -44.823% |
| Ind-Swift Limited | 10.13 Billion INR | 79.569% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 37.753% |
| Sakar Healthcare Limited | 793.51 Million INR | -161.082% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 96.884% |
| Innova Captab Limited | 2.45 Billion INR | 15.476% |
| Divi's Laboratories Limited | 30 Million INR | -6805.747% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -4405.511% |
| Morepen Laboratories Limited | 289.99 Million INR | -614.407% |
| Sequent Scientific Limited | 4.87 Billion INR | 57.52% |
| Wanbury Limited | 1.16 Billion INR | -77.854% |
| Laurus Labs Limited | 25.77 Billion INR | 91.962% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 67.402% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -1108.143% |
| Alembic Limited | 91.5 Million INR | -2164.179% |
| Hikal Limited | 8.17 Billion INR | 74.66% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 59.628% |
| Neuland Laboratories Limited | 953.89 Million INR | -117.186% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 45.143% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 83.169% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -532.394% |
| Themis Medicare Limited | 957.92 Million INR | -116.273% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 74.239% |
| Lupin Limited | 29.21 Billion INR | 92.909% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -11887.062% |
| Wockhardt Limited | 23.56 Billion INR | 91.207% |
| Vaishali Pharma Limited | 134.91 Million INR | -1435.543% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 27.372% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -2217.105% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 94.346% |
| FDC Limited | 205.18 Million INR | -909.686% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 89.652% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -554.646% |
| Eris Lifesciences Limited | 27.81 Billion INR | 92.551% |
| Venus Remedies Limited | 413.3 Million INR | -401.264% |
| ZIM Laboratories Limited | 1.08 Billion INR | -90.373% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -107.504% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -10416.365% |
| Shilpa Medicare Limited | 9.37 Billion INR | 77.899% |
| Albert David Limited | 33.24 Million INR | -6132.249% |
| Ajanta Pharma Limited | 352.8 Million INR | -487.223% |
| Hester Biosciences Limited | 2.44 Billion INR | 15.225% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -218.744% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 79.518% |
| Gufic Biosciences Limited | 3.32 Billion INR | 37.77% |
| Windlas Biotech Limited | 36.41 Million INR | -5589.986% |
| Procter & Gamble Health Limited | 95.6 Million INR | -2067.075% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -560.788% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -110.343% |
| Granules India Limited | 13.15 Billion INR | 84.246% |
| Aarti Drugs Limited | 5.64 Billion INR | 63.285% |
| Bal Pharma Limited | 1.39 Billion INR | -48.353% |
| Alkem Laboratories Limited | 14.18 Billion INR | 85.394% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 93.672% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -19319.985% |
| Medicamen Biotech Limited | 308.17 Million INR | -572.262% |
| Unichem Laboratories Limited | 2.47 Billion INR | 16.299% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -749.44% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -47102.643% |
| Valiant Laboratories Limited | 767.08 Million INR | -170.078% |
| Orchid Pharma Limited | 1.35 Billion INR | -53.256% |
| Medico Remedies Limited | 80.5 Million INR | -2473.442% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -1146.405% |
| Ipca Laboratories Limited | 14.38 Billion INR | 85.597% |
| Brooks Laboratories Limited | 56.41 Million INR | -3572.032% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -185.808% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.613% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 94.849% |
| NATCO Pharma Limited | 3.71 Billion INR | 44.188% |
| Suven Life Sciences Limited | 7.09 Million INR | -29091.546% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -7.105% |
| Strides Pharma Science Limited | 25.16 Billion INR | 91.769% |
| Indoco Remedies Limited | 6.71 Billion INR | 69.169% |
| Alpa Laboratories Limited | 52.46 Million INR | -3848.773% |
| Lasa Supergenerics Limited | 220.76 Million INR | -838.442% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -238.794% |